For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

Cancer Biology (CBIO) Faculty

  • Jane Azizkhan-Clifford, PhD

    Professor and Chair; Associate Dean for Medical Student Research
    Department: Biochemistry & Molecular Biology
    Research Interests: Cellular response to DNA damage, regulation of gene expression, cellular proliferation and the cell cycle

  • Michael Bouchard, PhD

    Director, Division of Biomedical Science Programs; Professor
    Department: Biochemistry & Molecular Biology
    Research Interests: Liver cancer; hepatocyte transformation; calcium signaling; apoptosis; cell proliferation; alcohol; novel liver models; hepatitis B virology and hepatic cancer; HBx protein and hepatitis viral replication; calcium signaling and its role in cellular transformation; fatty liver disease and the gut microbiome axis

  • Alessandro Fatatis, MD, PhD

    Professor
    Department: Pharmacology & Physiology
    Research Interests: Cellular and molecular mechanisms regulating metastatic potential of solid tumors, studies in vitro and in animal models of neoplastic disease

  • Edward Hartsough, PhD

    Assistant Professor
    Department: Pharmacology & Physiology
    Research Interests: Mechanisms contributing to metastatic progression and susceptibility of cancers to targeted inhibitors

  • Eishi Noguchi, PhD

    Associate Professor; Director, Graduate Program in Molecular & Cellular Biology & Genetics
    Department: Biochemistry & Molecular Biology
    Research Interests: Genome maintenance mechanisms relevant to the biology of cancer and aging, including DNA replication, DNA repair, DNA damage response and cell cycle checkpoints; investigating the mechanisms required for preservation of genomic integrity in response to environmental factors and toxins, including alcohol and aldehydes

  • Mauricio Reginato, PhD

    Professor; Director, Graduate Program in Cancer Biology
    Department: Biochemistry & Molecular Biology
    Research Interests: Molecular mechanisms underlying breast cancer growth, survival and spread to distinct organs, in particular how cancer genes alter metabolic pathways and how these pathways may be exploited to target cancers

  • Todd Strochlic, PhD, VMD

    Assistant Professor
    Department: Biochemistry & Molecular Biology
    Research Interests: Protein kinases, oncogenic signaling, breast cancer, and Drosophila oogenesis

 
Faculty at the Baruch S. Blumberg Institute
 

Ying-Hsiu Su, PhD

Adjunct Associate Professor
Research Interests:
Development of urine DNA-based genetic tests that would provide early detection of new and recurrent cancers and be an effective tool for personalized medicine.


 
Faculty in the Department of Biology at Drexel University
 

Nianli Sang, PhD

Research Interests: Regulation of cell metabolism and its relevance in major human diseases such as cancer, cardiovascular disorders and diabetes.

Elias Spiliotis, PhD

Research Interests: Understanding the molecular mechanisms that underlie the morphogenesis of epithelial and neuronal tissues. Focus on regulation of the cytoskeleton and its functions by a novel family of GTP-binding proteins termed septins.


 
Adjunct Faculty at the Wistar Institute
 

Dario Altieri, MD *

Research Interests: The mechanisms that underlie how tumor cells survive and proliferate in cancer, in particular how tumor cells evade the normal processes that cause cells with genetic faults to self-destruct.

Qing Chen, MD, PhD *

Research Interests: The molecular mechanisms of brain metastasis originating from primary tumors like breast cancer, and the interplay between cancer cells and the stromal cells that populate the brain microenvironment.

Dmitry Gabrilovich, MD, PhD *

Research Interests: Understanding of the role of tumor microenvironment in regulation of immune responses in cancer and tumor progression with specific emphasis on meyloid cells.

Alessandro Gardini, PhD

Research Interests: The epigenetic control of transcription during cell differentiation and oncogenesis.

Chih-Chi Andrew Hu, PhD

Research Interests: Research interests include the analysis of the mechanisms of B-cell development and B-cell cancer formation. He investigates endoplasmic reticulum-associated stress signaling molecules, which play important roles in the quality control of secretory and integral membrane proteins.

Paul Lieberman, PhD

Research Interests: How certain viruses, including Epstein-Barr virus and Kaposi's sarcoma–associated herpesvirus, establish a long-term latent infection that can lead to cancer.

Luis Montaner, DVM, DPhil *

Research Interests: Mechanisms of disease in HIV-1 infection, and explores new ways to boost the natural function of the immune system in order to combat infection or viral-associated disease.

Maureen Murphy, PhD

Research Interests: The most frequently mutated gene in human cancer, the tumor suppressor protein p53, especially how genetic polymorphisms in the p53 tumor suppressor gene that are more common in African Americans affect the ability of this protein to induce apoptosis and growth arrest, and hence combat tumor development.

Yulia Nefedova, MD, PhD *

Research Interests: Her research focuses on understanding molecular mechanisms by which the bone marrow microenvironment promotes tumor survival and progression.

Joseph M. Salvino, PhD

Research Interests: Medicinal chemistry, lead optimization and drug development, organic synthesis, design and synthesis of chemical biology tools to assist in mechanistic studies.

Kavitha Sarma, PhD

Research Interests: Dr. Sarma studies the mechanisms of RNA-mediated epigenetic gene regulation to understand how the loss of chromatin modifier-RNA interactions impacts cellular function.

Zachary Schug, PhD

Research Interests: Dr. Schug is interested in investigating metabolic adaptation in cancer cells through the use of cell biology, biochemistry, and metabolomics.

David Speicher, PhD

Research Interests: The use of proteomics, computational methods and biophysical approaches to characterize the roles of normal and mutant proteins in cancers and other human diseases. One approach uses systems biology strategies to better understand tumor progression and resistance to cancer therapeutics.

Jessie Villanueva, PhD

Research Interests: Our lab studies the molecular pathways that become deregulated in melanoma aiming at identifying suitable targets for therapy, particularly for tumors with limited treatment options, such as those driven by oncogenic NRAS. Our research goals are to dissect the mechanisms mediating drug resistance and identifying new targets or vulnerabilities that can be therapeutically exploited to combat melanoma drug resistance.

Rugang Zhang, PhD

Research Interests: The mechanisms that underlie how normal mammalian cells age and how tumor cells evade the process and become transformed, in particular how alterations in epigenetics lead to the evasion of the aging process during tumor development.


 
Adjunct Faculty at Lankenau Institute for Medical Research
 

Alexander Muller, PhD

Research Interests: Understanding molecular and genetic interactions that exist between tumors and the host environment as the basis for developing novel approaches for achieving effective therapeutic intervention.

Janet Sawicki, PhD

Research Interests: Developing new therapeutic strategies for improving the treatment of metastatic cancers, including prostate, ovarian, pancreatic, and cervical cancers based on the delivery of genetic material (i.e., DNA or RNA) to tumor cells.


 
Adjunct Faculty at Fox Chase Cancer Center
 

Sanjeevani Arora, PhD

Research Interests: My laboratory seeks to understand how innate differences in DNA replication and/or repair impact two critical areas in precision oncology: (1) what underlies an individual’s cancer risk, and (2) how an individual will respond to cancer treatment.

Alfonso Bellacosa, MD, PhD *

Research Interests: DNA repair of mismatched bases and the cellular response to DNA damage. Identification of early genetic alterations in tumorigenesis.

Jonathan Chernoff, MD, PhD *

Research Interests: Signal transduction by small G proteins and their effectors and the role of these proteins in regulating cytoskeletal structure, tumor invasion, and metastasis; regulation of insulin signaling.

Denise Connolly, PhD

Research Interests: Goal of our research is to discover ways to improve the treatment of epithelial ovarian cancer.

Edna Cukierman, PhD

Research Interests: Tumor microenvironment; we study cancer-associated fibroblasts and self-derived extracellular matrices to understand their biochemical and mechanical effects on tumorigenesis and stromal activation.

Roland Dunbrack, PhD

Research Interests: Computational structural biology, including homology modeling, fold recognition, molecular dynamics simulations, statistical analysis of the PDB, and bioinformatics.

Erica Golemis, PhD

Research Interests: Integration of systems biology approaches with high throughput screening and targeted pathway analysis to improve the efficacy of preclinical and clinical cancer therapies.

Eileen K. Jaffe, PhD

Research Interests: Protein quaternary structure dynamics; the morpheein model of allosteric regulation; quaternary structure as a basis for understanding disease and discovering drugs.

Ekaterina Koltsova, MD, PhD *

Research Interests: Lab focus is aimed to define and characterize immune–mediated mechanisms helping to regulate the inflammation in various immune-mediated pathologies such as atherosclerosis, AAA, obesity and cancer.

Warren D. Kruger, PhD

Research Interests: Molecular chaperone correction of missense mutations; genetic defects of methionine metabolic enzymes and human disease.

Jeffrey Peterson, PhD

Research Interests: Understanding how the Rho family of signaling proteins function in normal cells and how their signaling is altered in cancer and metastasis.

Lori Rink, PhD

Research Interests: Mechanisms of drug resistance in gastrointestinal stromal tumor.

Tim Yen, PhD

Research Interests: The mechanisms that regulate genome stability and how these processes are disrupted in cancer cells; mechanisms in cancer cells that promote their survival in response to chemotherapy using hi-throughput siRNA and small molecule screens; development of assays including imaging and biochemical assays.


* Physician's practice is independent of Drexel Medicine and Drexel University.

 

A Cancer Biology program graduate student working in the lab at Drexel University College of Medicine.